Robert Bindert Huizinga
Officer at Aurinia Pharmaceuticals Inc. (AUPH)
Robert Bindert Huizinga has filed 6 insider reports with the SEC since May 2021, as officer at Aurinia Pharmaceuticals Inc. (AUPH). Robert Bindert Huizinga made no open-market purchases or sales in the last 12 months. In the latest filing, on March 4, 2022, Robert Bindert Huizinga sold 4,849 shares of Aurinia Pharmaceuticals Inc. (AUPH) for $58.2K at an average of $12.01.
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- $5.48M
Companies where Robert Bindert Huizinga is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | 69,379 | $5.48M | $15.13 | Mar 4, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 2, 2022-$58.2KAUPHSEC Form 4: Huizinga Robert Bindert was granted 8,500 shares and sold $58,236 worth of shares (4,849 units at $12.01), increasing direct ownership by 6% to 69,379 units (for withholding tax)Form 4Grant or awardOpen-market sale
- Oct 25, 2021-$3.87MAUPHSEC Form 4: Huizinga Robert Bindert exercised 95,000 shares at a strike of $3.20 and sold $3,867,500 worth of shares (130,000 units at $29.75) as part of a pre-agreed trading plan, decreasing direct ownership by 35% to 65,728 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 21, 2021-$780KAUPHSEC Form 4: Huizinga Robert Bindert exercised 27,136 units of Common Stock at a strike of $2.86 and sold $779,533 worth of Common Stock (32,500 units at $23.99), decreasing direct ownership by 5% to 100,728 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 14, 2021-$687KAUPHSEC Form 4: Huizinga Robert Bindert sold $687,325 worth of Common Stock (32,500 units at $21.15), decreasing direct ownership by 23% to 106,092 unitsForm 4Open-market sale10b5-1 plan
- Sep 7, 2021-$91.5KAUPHSEC Form 4: Huizinga Robert Bindert sold $91,500 worth of Common Stock (5,000 units at $18.30), decreasing direct ownership by 3% to 138,592 unitsForm 4Open-market sale10b5-1 plan
- May 11, 2021AUPHSEC Form 4: Huizinga Robert Bindert exercised 40,000 units of Common Stock at a strike of $3.02, increasing direct ownership by 39% to 143,592 unitsForm 4Exercise or conversion of a derivative
Compare Robert Bindert Huizinga with
- Robert Bindert Huizinga vs Stephen P. Robertson1 shared
- Robert Bindert Huizinga vs Craig A Johnson1 shared
- Robert Bindert Huizinga vs Kathleen Goetz1 shared
- Robert Bindert Huizinga vs Tina Susan Nova1 shared
- Robert Bindert Huizinga vs Jeffrey Allen Bailey1 shared
- Robert Bindert Huizinga vs Kevin Tang1 shared
Other insiders at the same companies
- Stephen P. RobertsonAUPH
- Craig A JohnsonAUPH
- Kathleen GoetzAUPH
- Tina Susan NovaAUPH
- Jeffrey Allen BaileyAUPH
- Kevin TangAUPH
- Michael S HearneAUPH
- Ryan ColeAUPH
- Peter GreenleafAUPH
- Matthew Maxwell DonleyAUPH
- Greg KeenanAUPH
- Joseph M MillerAUPH
- Karen L. SmithAUPH
- Jill LeversageAUPH
- David R.W. JayneAUPH
Questions about Robert Bindert Huizinga
- What is Robert Bindert Huizinga's role at Aurinia Pharmaceuticals Inc.?
- Robert Bindert Huizinga reports to the SEC as officer at Aurinia Pharmaceuticals Inc. (AUPH), according to the latest filing on March 4, 2022.
- How many shares does Robert Bindert Huizinga own?
- After the latest filing that states it, Robert Bindert Huizinga directly owned 69,379 shares of Aurinia Pharmaceuticals Inc. (AUPH). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert Bindert Huizinga bought or sold stock recently?
- The most recent open-market sale was on March 2, 2022: sold 4,849 shares of Aurinia Pharmaceuticals Inc. (AUPH) for $58.2K at an average of $12.01.
- How do I get alerts when Robert Bindert Huizinga files?
- Follow Robert Bindert Huizinga on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Robert Bindert Huizinga (SEC CIK 0001837648). Totals count each trade once, skipping amendments whose original is on file, from May 11, 2021 on. View on SEC EDGAR